Artivion, Inc. (AORT) vs Beta Bionics, Inc. (BBNX)
Artivion, Inc. and Beta Bionics, Inc. are both Medical Devices companies. Artivion, Inc. and Beta Bionics, Inc. are of similar size ($1.2B and $1.1B). Beta Bionics, Inc. grew revenue faster over the last twelve months: 52.5% against 16.4%. Artivion, Inc. has the higher net margin (−0.67% vs −61.3%) and the higher return on invested capital (1.76% vs −68.5%). Across the 17 metrics below, Artivion, Inc. leads on 14 and Beta Bionics, Inc. on 3.
Valuation
Profitability
| Metric | AORT | BBNX | Medical Devices median |
|---|---|---|---|
| Gross margin | 64.37% | 58.31% | 56.01% |
| Operating margin | 4.38% | (69.75%) | (15.03%) |
| Net margin | (0.67%) | (61.32%) | (20.40%) |
| Free cash flow margin | (1.94%) | (284.13%) | (7.24%) |
| Return on equity | (0.73%) | (26.16%) | (15.32%) |
| Return on assets | (0.33%) | (23.45%) | (19.72%) |
| Return on invested capital | 1.76% | (68.47%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack